John Johnson

Director

Director at Xeris Biopharma Holdings, Inc., filing insider transactions between 2025-08-13 and 2026-06-04. Also reports transactions at 1 other company.

Total Purchases

—

0 transactions

Total Sales

$2.3M

4 transactions

Companies Traded

4 total filings

Active Since

2025-08-13

Last: 2026-06-04

Companies

XERS2026-06-04

Xeris Biopharma Holdings, Inc.

↓ $1.9M (3)

AXGN2026-05-07

Axogen, Inc.

↓ $478K (1)

Other Reporting Insiders at Xeris Biopharma Holdings, Inc.

Steven Pieper
See Remarks
Last filing 2026-10-01
Kevin McCulloch
See Remarks
Last filing 2026-10-01
Beth Hecht
See Remarks
Last filing 2026-10-01
Barbara-Jean Anne Bormann-Kennedy
Director
Last filing 2026-06-04
Dawn Halkuff
Director
Last filing 2026-06-04
Marla Persky
Director
Last filing 2026-06-03
Beth Hecht
See Remarks
Last filing 2026-06-01

Transaction History

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-06-04	XERS	Sale	15.0K	$6.09	$91K	683.1K	SEC ↗
2026-05-07	AXGN	Sale	11.1K	$43.26	$478K	0	SEC ↗
2025-12-19	XERS	Sale	135.4K	$7.22	$977K	698.1K